Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
Phase II Research Study of Arsenic Trioxide (Trisenox) in Patients With Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00225992. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT05693909. IPD Sharing: NO. Countries: 1. Publications: 0.
Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT04047641. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine
ClinicalTrials.gov study NCT02489929. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Physical Activity in Transfusion Dependent Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT04969367. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease
ClinicalTrials.gov study NCT00295971. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Pevonedistat Combined With Decitabine and Cedazuridine in Adults With Higher-risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT04985656. IPD Sharing: YES. Countries: 0. Publications: 0.
Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients
ClinicalTrials.gov study NCT01951430. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of HS-20106 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT06594965. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Dasatinib and All-Trans Retinoic Acid for Relapsed/Refractory and/or Elderly Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00892190. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01065129. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Response of SLN124 in Adults With Alpha/Beta-thalassaemia and Very Low- and Low-risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT04718844. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Study of KHK2823 in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02181699. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of Anemia With Epoetin Beta in Low Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02428686. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT05038592. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia
ClinicalTrials.gov study NCT00005892. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers
ClinicalTrials.gov study NCT00899795. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT07216443. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of IMM01 Combined With Azacitidine in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
ClinicalTrials.gov study NCT05140811. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fostamatinib for the Treatment of Lower-risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia Who Have Failed Therapy With Hypomethylating Agents
ClinicalTrials.gov study NCT05030675. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.